Compare REE & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REE | TRIB |
|---|---|---|
| Founded | 2011 | 1992 |
| Country | Israel | Ireland |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.7M | 18.3M |
| IPO Year | N/A | N/A |
| Metric | REE | TRIB |
|---|---|---|
| Price | $0.75 | $1.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $11.75 | N/A |
| AVG Volume (30 Days) | 109.4K | ★ 8.8M |
| Earning Date | 12-17-2025 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $183,000.00 | ★ $49,409,000.00 |
| Revenue This Year | $327.73 | $13.51 |
| Revenue Next Year | $36,888.82 | $13.14 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 8.31 |
| 52 Week Low | $0.53 | $0.48 |
| 52 Week High | $10.24 | $3.44 |
| Indicator | REE | TRIB |
|---|---|---|
| Relative Strength Index (RSI) | 49.49 | 51.23 |
| Support Level | $0.65 | $0.87 |
| Resistance Level | $0.82 | $1.75 |
| Average True Range (ATR) | 0.07 | 0.16 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 62.99 | 17.90 |
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.